Genomic Medicine PGDip (DL)
Queen Mary University of London · England · P900238
Genomic Medicine PGDip (DL) is a degree at Queen Mary University of London, England. It covers areas like clinical genetics, computational biology, genomics, clinical skills, cancer biology, molecular biology. The summary below is compiled from public course information — approximate, not official.
Queen Mary University of London
What you'll study in Genomic Medicine PGDip (DL)
Example subjects: Professional and Research Skills, Molecular Pathology of Cancer and Application in Cancer Diagnosis, Bioinformatics, Interpretation, and Data Quality Assurance in Genome Analysis, Economic Models and Human Genomics.
Frequently asked questions
What will I study in Genomic Medicine PGDip (DL)?
Genomic Medicine PGDip (DL) covers areas like clinical-genetics, computational-biology, genomics, genetics, health-economics, bioinformatics, professional-experience, economic-history.
Who offers Genomic Medicine PGDip (DL)?
Genomic Medicine PGDip (DL) is offered by Queen Mary University of London, England.
Considering Genomic Medicine PGDip (DL)?
Peernovo helps students research, choose and thrive at university — across Australia, the US, the UK and Canada — powered by our AI backbone:
- Explore & compare degrees — across universities and countries with honest, specific information.
- "What Can I Be?" career guidance — an AI pathway councillor that maps degrees to careers.
- See who's studying — your degree at your university — find classmates and study groups.
- AI Task Coach — a Socratic study companion that plans your work around your life.
- Honours & Thesis Research Coach — structure and move your research project forward.
- Smart study planner, exam prep and a daily digest — to keep you on track.
Sources: Queen Mary University of London official course page. Information is compiled and summarised — not copied verbatim — and is approximate; always confirm with the original source.
Something not right on this page, or want it changed? Let us know and we'll review it.